Regenerative strategies built around cell-based therapies are rapidly advancing through the field of stem cell & regenerative medicine. Harnessing the plasticity of embryonic, adult, and induced pluripotent stem cells, researchers are developing treatments for degenerative diseases, traumatic injuries, and organ failure. These cells serve as building blocks for regenerating damaged tissues and restoring physiological function. Breakthroughs in 3D scaffolding, organoid development, and bioprinting allow for realistic tissue reconstruction and disease modeling. Stem Cell & Regenerative Medicine is also at the forefront of clinical applications in orthopedics, cardiology, and neurology. With the integration of gene editing and immunomodulation, the therapeutic potential of stem cells is becoming more precise and patient-specific—moving regenerative therapies closer to routine clinical practice.
Title : Biotech innovations: Bioengineering potential for novel biomanufacturing systems
Murray Moo Young, University of Waterloo, Canada
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Stem cell therapy: An affordable healthcare therapy for various diseases
Anant Marathe, Total Potential Cells (P) Ltd, India
Title : Eliminating implant infection: 30,000 nanotextured implants in humans with no failure
Thomas J Webster, Interstellar Therapeutics, United States
Title : Development and characterization of exo-ITC: A fibrous bilayer exosome delivery system for dermatological applications
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Information leakage: Types, remedies, and open problems
Julia Sidorova, Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain